However, a recent study demonstrated that abrupt termination of statin therapy resulted in a rebound in inflammatory marker levels, such as a rapid increase in interleukin‐6 (IL‐6) levels, in patients with hypercholesterolemia (Li et al., 2006). Here, IL6 is linked to familial hypercholesterolemia.